Microbot Medical
TSX:Not availableLive AI agent
Microbot Medical is dedicated to delivering transformative interventional robotic solutions that prioritize patient care, empower healthcare providers, and enable access to advanced care anytime and anywhere.
Investor website: https://microbotmedical.com/
We don’t have processed documents for Microbot Medical yet, so the AI assistant isn’t available on this page.
About
Microbot Medical is dedicated to delivering transformative interventional robotic solutions that prioritize patient care, empower healthcare providers, and enable access to advanced care anytime and anywhere. The company is focused on creating a new category of surgical robotics through its LIBERTY Endovascular Robotic System, emphasizing a patient-first mindset and collaboration throughout its development process.
Verified company data
- Shares outstanding
- 67,158,044
- Fully diluted shares
- 81,846,616
- Projects
- ["LIBERTY® Endovascular Robotic System\n\nPerformance Meets Precision\n\nStep into the next generation of endovascular intervention. LIBERTY® is engineered for physicians who demand control, efficiency and peace of mind.\n\nTest Drive LIBERTY™\n\nDrive the Future of Intervention™\n\nLIBERTY® delivers smooth, responsive peripheral endovascular navigation in a single-use, remotely operated design that fits seamlessly into your workflow. You are in command, even from across the room.\n\nTest Drive LIBERTY™\n\nA New Era in Endovascular Care\n\nUnlike traditional manual techniques, LIBERTY Endovascular Robotic System offers a single-use, compact solution that enables controlled remote operation while transforming vascular access and navigation without the complexity or cost of capital equipment.\n\nNo Large Capital Investment\n\nSingle-use without need for capital investment.\n\nReduce Radiation Exposure\n\n92% reduction in radiation exposure.1,2\n\nCompact Design\n\nCompact system integrates effortlessly into your existing workflow.\n\nControl and Comfort\n\nRemote, seated operation enables improved ergonomics.\n\nEfficient Set-Up\n\nSimple and intuitive setup in under 5 minutes.¹\n\nUniversal Compatibility\n\nCompatible with your preferred guidewires and catheters.\n\nAccuGrip™\n\nAccuGrip™ securely holds wires and catheters\n\nDownload LIBERTY® Brochure\n\nIntended Use and Indications for Use:\n\nThe LIBERTY Endovascular Robotic System is intended for use in the remote delivery and manipulation of guidewires and catheters, and remote manipulation of guide catheters to facilitate navigation to anatomical targets in the peripheral vasculature.\n\nThe LIBERTY Endovascular Robotic System is not intended for coronary or neurointerventional procedures.\n\n1Abstract No. LBA15 Remote-Controlled Endovascular Navigation with a Miniature, Single-Use, Robotic System. Results of the ACCESS-PVI Trial Cornelis, F. et al. Journal of Vascular and Interventional Radiology, Volume 36, Issue 3, S235 – S236\n\n2Data on file\n\n3Research report from wet-lab with nine experienced interventional radiologists. Set-up times and learning curve will vary with user\n\n*Within the product specifications\n\nThe LIBERTY® Starter Kit\n\nBegin your Robotics Program with Confidence\n\nThe LIBERTY® Starter Kit is designed to help you launch your endovascular robotics program with confidence and without the burden of long-term investment risk.\n\nNo hidden commitments.\n\nFull clinical training & support included.\n\nDiscounted volume to lower acquisition risk.\n\nGet Started Today\n\nReal- World Feedback from LIBERTY® Users\n\nSURVEYED USER RESPONSES¹:\n\n94% of respondents found LIBERTY easy to operate\n\n94% of respondents reported stable tool control\n\n92% of respondents cited LIBERTY as easy to set-up\n\n1Based on 48 LIBERTY® feedback survey responses across multiple procedure types."]
- Leadership
- Harel Gadot (CEO, President and Chairman), Simon Sharon (GM, Chief Technology Officer), Rachel Vaknin (Chief Financial Officer), Juan Diaz-Cartelle, MD (Chief Medical Officer), Earl Adamy (VP, Strategic Marketing & Business Development), Christina Bailey (VP, Sales), Eran Cohen (VP, Global Integration), Naama Moav (VP, Human Resources), Noa Ofer, PhD (VP, Quality Assurance and Regulatory Affairs), Allison Rosefort (VP, Marketing), Alon Tamir (VP, Sales, EMEA), Martin J. Madden (Director), Scott Burell (Director), Aileen Stockburger (Director), P. Laxminarain (Director), Tal Wenderow (Director), David Wilson (Director)
Verified data last updated: